Wei-Wu He is CEO & Chairman at CASI Pharmaceuticals, Inc. (CASI). They have made 19 open-market trades across 1 company since 2016, most recently 2022-06-15.
CIK 0001542073
19 open-market purchases totalling $61.8M since 2016, never a sale. Across 19 scored buys the stock is up 9.2% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
19 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CASI | 594,553 | $123K |
Shares reported on the most recent Form 4, priced at the 2022-06-17 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 37% | 37% | 53% |
| Avg Move | -0.8% | +1.6% | +9.2% |
| Alpha | -2.7% | -2.3% | +0.2% |
| Scored | 19 | 19 | 19 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CASI | BUY | 2022-06-13 | 2022-06-17 | $3.06 | $380K | -13.6% | -18.7% | +27.8% |
| CASI | BUY | 2021-11-17 | 2021-11-19 | $0.99 | $394K | -16.8% | -17.6% | -17.6% |
| CASI | BUY | 2021-08-18 | 2021-08-20 | $1.28 | $614K | +14.6% | -6.3% | -34.3% |
| CASI | BUY | 2021-03-26 | 2021-03-30 | $2.05 | $12.3M | -14.2% | -17.4% | -29.7% |
| CASI | BUY | 2020-11-20 | 2020-11-24 | $2.15 | $976K | -19.2% | +0.7% | -5.8% |
| CASI | BUY | 2020-07-22 | 2020-07-24 | $1.90 | $13.5M | -4.0% | -14.5% | -20.0% |
| CASI | BUY | 2020-05-19 | 2020-05-21 | $2.25 | $389K | +0.4% | -2.3% | -28.8% |
| CASI | BUY | 2020-05-15 | 2020-05-19 | $1.99 | $1.6M | +22.8% | +16.7% | -12.1% |
| CASI | BUY | 2020-03-27 | 2020-03-30 | $2.08 | $14K | -6.2% | -6.2% | +18.2% |
| CASI | BUY | 2020-03-25 | 2020-03-27 | $2.03 | $2.1M | -10.8% | -11.8% | +22.6% |
| CASI | BUY | 2020-03-17 | 2020-03-19 | $1.53 | $2.7M | +4.1% | -7.1% | +28.3% |
| CASI | BUY | 2019-08-16 | 2019-08-20 | $3.20 | $64K | +0.3% | +0.0% | +0.0% |
| CASI | BUY | 2019-08-14 | 2019-08-15 | $3.17 | $507K | -5.5% | +5.5% | +1.2% |
| CASI | BUY | 2018-03-19 | 2018-03-21 | $3.24 | $20.0M | +61.5% | +75.6% | +49.5% |
| CASI | BUY | 2017-10-10 | 2017-10-11 | $1.95 | $195K | -33.2% | -35.7% | -3.2% |
| CASI | BUY | 2017-10-05 | 2017-10-10 | $1.83 | $366K | -6.0% | -4.4% | +39.3% |
| CASI | BUY | 2017-09-18 | 2017-09-20 | $1.76 | $425K | -3.8% | +28.1% | +61.6% |
| CASI | BUY | 2017-09-14 | 2017-09-18 | $1.33 | $838K | -3.3% | +27.2% | +71.2% |
| CASI | BUY | 2016-10-03 | 2016-10-05 | $1.19 | $4.5M | +17.9% | +18.8% | +6.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.